NO20032591L - Fremgangsmåte for isolering og rensing av epotiloner - Google Patents

Fremgangsmåte for isolering og rensing av epotiloner

Info

Publication number
NO20032591L
NO20032591L NO20032591A NO20032591A NO20032591L NO 20032591 L NO20032591 L NO 20032591L NO 20032591 A NO20032591 A NO 20032591A NO 20032591 A NO20032591 A NO 20032591A NO 20032591 L NO20032591 L NO 20032591L
Authority
NO
Norway
Prior art keywords
epothilones
isolating
purifying
epothilone
desorption
Prior art date
Application number
NO20032591A
Other languages
English (en)
Other versions
NO20032591D0 (no
NO329164B1 (no
Inventor
Ernst Kuesters
Heinz Unternaehrer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20032591L publication Critical patent/NO20032591L/no
Publication of NO20032591D0 publication Critical patent/NO20032591D0/no
Publication of NO329164B1 publication Critical patent/NO329164B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)

Abstract

Foreliggende oppfinnelse angår en desorpsjonsprosess for epotiloner, særlig epotilon A og/eller epotilon B, fra harpikser og nye produksjons-, opparbeidings- eller rensingsprosesser eller fremstillingsfremgangsmåter for epotiloner som innbefatter nevnte desorpsjonsprosess, så vel som anvendelse av visse løsemidler for desorpsjon av epotiloner fra harpikser.
NO20032591A 2000-12-07 2003-06-06 Fremgangsmate for a desorbere, isolere og opparbeide epotiloner og anvendelse av svakt polare eller apolare losemidler for desorpsjon av epotiloner NO329164B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029895.0A GB0029895D0 (en) 2000-12-07 2000-12-07 Organic compounds
PCT/EP2001/014771 WO2002046196A1 (en) 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones

Publications (3)

Publication Number Publication Date
NO20032591L true NO20032591L (no) 2003-06-06
NO20032591D0 NO20032591D0 (no) 2003-06-06
NO329164B1 NO329164B1 (no) 2010-09-06

Family

ID=9904660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032591A NO329164B1 (no) 2000-12-07 2003-06-06 Fremgangsmate for a desorbere, isolere og opparbeide epotiloner og anvendelse av svakt polare eller apolare losemidler for desorpsjon av epotiloner

Country Status (31)

Country Link
US (2) US6946561B2 (no)
EP (1) EP1345944B1 (no)
JP (1) JP4287650B2 (no)
KR (1) KR100894990B1 (no)
CN (1) CN1263761C (no)
AR (1) AR031902A1 (no)
AT (1) ATE292132T1 (no)
AU (2) AU2002224936B2 (no)
BR (1) BR0115991A (no)
CA (1) CA2433414C (no)
CZ (1) CZ301664B6 (no)
DE (1) DE60109814T2 (no)
DK (1) DK1345944T3 (no)
EC (1) ECSP034641A (no)
ES (1) ES2239687T3 (no)
GB (1) GB0029895D0 (no)
HU (1) HU224910B1 (no)
IL (2) IL156088A0 (no)
MX (1) MXPA03005097A (no)
MY (1) MY128409A (no)
NO (1) NO329164B1 (no)
NZ (1) NZ526197A (no)
PE (1) PE20020568A1 (no)
PL (1) PL209406B1 (no)
PT (1) PT1345944E (no)
RU (1) RU2285007C2 (no)
SI (1) SI1345944T1 (no)
SK (1) SK287356B6 (no)
TW (1) TWI286137B (no)
WO (1) WO2002046196A1 (no)
ZA (1) ZA200304296B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
WO2004018478A2 (en) * 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
KR20050053681A (ko) * 2002-09-23 2005-06-08 브리스톨-마이어스 스큅 컴퍼니 에포틸론 ｂ의 제조, 분리 및 정제 방법, 및 에포틸론 ｂ의ｘ-선 결정 구조
FR2846520B1 (fr) 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
KR100681811B1 (ko) * 2005-03-15 2007-02-12 성균관대학교산학협력단 생물학적 대사부산물의 효율적인 제거를 통한 유용 이차대사산물의 제조방법
MY148355A (en) 2006-08-16 2013-03-29 Novartis Ag Crystal form of epothilone b and use in pharmaceutical compositions
WO2009100571A1 (zh) 2008-02-01 2009-08-20 Zhejiang Hisun Pharmaceutical Co., Ltd. 一种分离和提纯埃博霉素的方法
CN103037903A (zh) 2010-05-18 2013-04-10 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 ａ와 ｂ의 추출 및 정제 방법
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
AU716610B2 (en) * 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
JP4274583B2 (ja) * 1996-11-18 2009-06-10 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ） エポチロンｃ，ｄ，ｅ及びｆ、製造と薬剤
ES2184307T3 (es) * 1997-07-16 2003-04-01 Schering Ag Derivados de tiazol, procedimiento para su preparacion y su utilizacion.
US6365749B1 (en) * 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19826988A1 (de) * 1998-06-18 1999-12-23 Biotechnolog Forschung Gmbh Epothilon-Nebenkomponenten
DE60114865T2 (de) * 2000-04-28 2006-07-27 Kosan Biosciences, Inc., Hayward Heterologe herstellung von polyketiden
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US7569698B2 (en) 2009-08-04
CA2433414C (en) 2011-01-25
DK1345944T3 (da) 2005-05-30
PL361884A1 (en) 2004-10-04
SK6892003A3 (en) 2004-01-08
HU224910B1 (en) 2006-04-28
RU2285007C2 (ru) 2006-10-10
NO20032591D0 (no) 2003-06-06
IL156088A0 (en) 2003-12-23
NZ526197A (en) 2005-01-28
MY128409A (en) 2007-01-31
CZ20031565A3 (cs) 2003-10-15
JP4287650B2 (ja) 2009-07-01
CN1479741A (zh) 2004-03-03
HUP0302579A2 (hu) 2003-11-28
ECSP034641A (es) 2003-07-25
HK1059618A1 (en) 2004-07-09
CN1263761C (zh) 2006-07-12
DE60109814D1 (de) 2005-05-04
AU2002224936B2 (en) 2005-09-22
KR20030053535A (ko) 2003-06-28
AU2493602A (en) 2002-06-18
EP1345944B1 (en) 2005-03-30
NO329164B1 (no) 2010-09-06
CZ301664B6 (cs) 2010-05-19
PE20020568A1 (es) 2002-07-22
IL156088A (en) 2008-08-07
ES2239687T3 (es) 2005-10-01
US20050288514A1 (en) 2005-12-29
US6946561B2 (en) 2005-09-20
BR0115991A (pt) 2004-01-13
AR031902A1 (es) 2003-10-08
TWI286137B (en) 2007-09-01
ATE292132T1 (de) 2005-04-15
PT1345944E (pt) 2005-08-31
PL209406B1 (pl) 2011-08-31
HUP0302579A3 (en) 2004-10-28
MXPA03005097A (es) 2003-09-05
CA2433414A1 (en) 2002-06-13
WO2002046196A1 (en) 2002-06-13
ZA200304296B (en) 2004-04-23
DE60109814T2 (de) 2006-02-16
GB0029895D0 (en) 2001-01-24
KR100894990B1 (ko) 2009-04-24
EP1345944A1 (en) 2003-09-24
JP2004521879A (ja) 2004-07-22
SI1345944T1 (sl) 2005-12-31
SK287356B6 (sk) 2010-08-09
US20040054188A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
EP1328282A4 (en) EFFICIENT METHOD FOR PRODUCING COMPOSITIONS ENRICHED WITH ANTHOCYANINS
EA200800358A1 (ru) Способ извлечения диоксида углерода высокой степени чистоты из газообразных источников, содержащих соединения азота
MY128409A (en) Process for the isolation and purification of epothilones
WO2004026254A3 (en) Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
WO2007076392A3 (en) A method for reusing rhenium from a donor spent epoxidation catalyst
EP1997817A4 (en) METHOD FOR PURIFYING ETHYLENE CARBONATE, PROCESS FOR PREPARING CLEANED ETHYLENE CARBONATE AND ETHYLENE CARBONATE
PL1896389T3 (pl) Sposób otrzymywania dronabinolu z kannabidiolu z zastosowaniem sita molekularnego
NO20074215L (no) Fremgangsmate for reduksjon og/eller rensing av metallholdig slagg
WO2008108429A1 (ja) ２－メチル－３－（３，４－メチレンジオキシフェニル）プロパナールの品質保持方法、及びその製造方法
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
WO2004060277A3 (en) Process for purification of plasmid dna
WO2003012100A3 (en) Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids
DK1362021T3 (da) Fremgangsmåde til at ekstrahere, fraktionere og oprense polyphenolforbindelser stammende fra frisk vegetabilsk affald ved anvendelse af en harpiks med höjt absorptionsudbytte og elueringsudbytte
UA90188C2 (ru) Способ выделения кислот из реакционных смесей и способ получения триамидов тиофосфорной кислоты
WO2004113315A3 (en) Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media
ATE542810T1 (de) Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
EA200500329A1 (ru) Способ получения глюкозы из целлюлозосодержащего сырья, преимущественно отходов пивного производства
NO20033860L (no) Fremgangsmåte for fjernelse av kalsium fra en sulfatopplösning i sinkprosess
DE602005026099D1 (de) Transformierte saccharomyces cerevisiae sowie verfahren zur massenproduktion des proteins lk8 damit
ITRM20010477A1 (it) Procedimento per la produzione o rigenerazione di un pneumatico, comepure dispositivo di riporto di battistrada.
WO2009088255A3 (en) Method for preparing antigen effective for preventing anthrax infection
ATE402157T1 (de) Verfahren zur herstellung von mycophenolatmofetil
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan
WO2007017277A8 (en) METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)
DE60219341D1 (de) Verfahren zur hydrierung von aceton

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees